Navigation Links
Vasomedical Retains KCSA Strategic Communications as Corporate Communications Counsel
Date:10/31/2012

WESTBURY, N.Y., Oct. 31, 2012 /PRNewswire/ -- Vasomedical, Inc. ("Vasomedical") (OTCQB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology as well as in the domestic sale of diagnostic imaging products, announced today that it has retained KCSA Strategic Communications (KCSA), a leading New York-based communications firm, to direct the Company's investor relations and public relations programs.

(Logo: http://photos.prnewswire.com/prnh/20120517/NY09396LOGO)  

KCSA will deploy an integrated investor and public relations campaign designed to increase awareness of Vasomedical, its proprietary technology and its business model among the investment community, targeting the healthcare and medical device sectors, in addition to outreach to business and trade publications.

Since KCSA's inception more than 40 years ago, the firm has developed a strong reputation for its work representing domestic and international companies across all industries, including medical devices, healthcare services and biotechnology. Todd Fromer and Lewis Goldberg, Managing Partners of KCSA, will lead the communications team and provide strategic counsel on financial and media communication matters.

"We understand the importance of a proactive communications program to effectively reach the investment community in general, our shareholders in particular, as well as the media. As we continue to grow our business, we look forward to working closely with KCSA to effectively communicate our growth strategy and operational progress through all of the appropriate channels. As our superior healthcare solutions move into global markets, we see increased demand from healthcare professionals, distributors and consultan
'/>"/>

SOURCE KCSA Strategic Communications
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
2. ViaCyte Receives $10.1 Million Strategic Partnership Award from CIRM to Continue Development of Diabetes Therapy
3. PPCE Announces Strategic Partnership With ECLINSO AG
4. Sage Products Joins APIC Strategic Partner Program
5. CMC Biologics Establishes Commercial Presence in Japan through Strategic Agreement with Innomedica
6. Strategic Agreement Launches Novel Drug Development Model
7. Frost & Sullivan Lauds U-Systems for Its Unique Technology and Strategic Excellence Paving the Way for Robust Growth
8. Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
9. Physicians Capital Investments, Physicians Capital Markets, and EDGE Realty Capital Markets announce a new strategic initiative
10. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
11. Frost & Sullivan Recognizes Rosetta Genomics for Its Strategic Excellence and Strong Contribution to Next-Generation Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  A recently published ... Houston, Texas , demonstrates that 3D ... increasing cancer detection. The study, "Implementation ... Observational Study," was led by Stephen L. ... issue of the American Journal of Roentgenology ...
(Date:5/23/2013)... -- More than half of women diagnosed with early ... still have excellent outcomes. To educate women, Agendia, Inc. ... sources of online consumer information about breast cancer genomic ... recently diagnosed women with information sources, to help them ... "We anticipate these innovative social media campaigns will encourage ...
(Date:5/23/2013)... 2013  Every day, their baby stopped breathing, his collapsed ... April and Bryan Gionfriddo watched helplessly, ... "Quite a few doctors said he had a good ... April Gionfriddo , about her now 20-month-old son, Kaiba. ... we would take it and run with it." ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4
... -- Gentech Pharmaceutical, announced today it will be front and ... giving away freebies to the Hollywood elite from their display ... as part of the giveaways as the official weight loss ... in the GBK Gift Lounge on January 13th and 14th ...
... 5, 2012 /PRNewswire-iReach/ -- FutureNet,s Ambulatory ... government,s "meaningful use" stamp of approval by earning ... 5.2 software capable of enabling ambulatory/outpatient providers to ... Reinvestment Act (ARRA). Tested and certified under the ...
Cached Medicine Technology:Golden Globe Awards Adds Gentech Pharmaceutical as New Participating Sponsor 2FutureNet Granted Certification for Cloud-based Ambulatory EHR 2FutureNet Granted Certification for Cloud-based Ambulatory EHR 3
(Date:5/23/2013)... 2013 Susquehanna Health is ... comprehensive babysitting training course for adolescents age 11 and ... Indianapolis pediatrician Dr. Patricia Keener after a colleague’s toddler ... adult sitter who didn’t know how to provide first ... with a medical basis that aims to reduce the ...
(Date:5/23/2013)... to its destruction inside a cell, a cancer-promoting ... thwart the development of tumor-suppressing microRNAs (miRNAs) before ... publication at Nature . , Under conditions ... epidermal growth factor receptor (EGFR) gums up the ... scientists at The University of Texas MD Anderson ...
(Date:5/23/2013)... used next generation genomic analysis to determine that some ... genetic origins, which may help in predicting cancer progression. ... Cancer Research . , "This is the first study ... adjacent Gleason patterns in the same tumor allowing us ... Cheville, M.D., Mayo Clinic pathologist and one of the ...
(Date:5/23/2013)... The Rottenstein Law Group LLP, a New ... Tylenol Lawsuit Information Center at http://www.rotlaw.com/tylenol , dedicated ... who are considering filing lawsuits. , The painkiller ... liver damage, according to a 2009 report from the ... communication,” the FDA warned consumers against using more than ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 Dr. ... her new charitable organization in Orange County, OCCares , ... in Orange County. The event details are as follows: ... Orangewood Academy Auditorium, 13732 Clinton Street, Garden Grove, CA 92843 ... pop crossover music by Christian vocalists Charmaine & Jonathan Thulin. ...
Breaking Medicine News(10 mins):Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 3Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 3
... 67-Year-Old Great-Grandmother & Geriatric Care Manager Marion Somers, PhD, Will Visit 15 ... ... Politicians, NEW YORK, Sept. 24 Leading ... today kicked off her second national bus tour this year to raise,awareness ...
... Campaign Supports Susan G. Komen for the Cure with its ... Auction this October, WHAT: Emmy Award-winning journalist and TV personality Cristina ... Project Pink Campaign. Munchkin, Inc. ... products -- is once again reminding women everywhere "Don,t Duck a ...
... YORK, Sept. 24 There is clear evidence,that ... added to U.S. water,supplies, present potential risks to ... (NRC) first-ever published review of the,fluoride/thyroid literature.(A) ... 2/3 of U.S.,public water supplies, ostensibly to reduce ...
... 2007 -- A new study reports important evidence ... diagnosed with schizophrenia. Schizophrenia is considered one ... disorders, which has three distinct facets, often referred ... reduced capacity for pleasure), and cognitive (impairments in ...
... methods significantly raise exam rate, study finds , MONDAY, ... doctors, offices can improve colorectal cancer screening rates, a ... most common kind of cancer and the third leading ... patients don,t experience any symptoms until the disease is ...
... Health Solutions, Inc.,("SXC" or the "Company") (NASDAQ: SXCI ... services, announces that Gordon S. Glenn,Chairman and Chief Executive ... Officer, will present at the 2007 UBS Global Life,Sciences ... SXC,s presentation,will take place on Tuesday, September 25, 2007 ...
Cached Medicine News:Health News:Elder Care Author Doctor Marion Launches Second National Tour to Raise Awareness About Aging & Elder Care Issues in America 2Health News:Cristina Saralegui Joins Celebrities Including Matthew McConaughey, Courteney Cox and Mariska Hargitay to Raise Money for Breast Cancer Research 2Health News:Fluoride Damages the Thyroid, Report Shows 2Health News:Potential new approach to treat cognitive impairments in schizophrenia 2Health News:Doctors' Office Outreach Boosts Colon Cancer Screening 2